Daniel Connell

Daniel Connell has extensive work experience in the pharmaceutical and biotechnology industry. Daniel is currently the Head of Strategic Alliances at C2N Diagnostics. Prior to this, they held senior positions at AstraZeneca, Biogen, Novartis Oncology, Roche, Monogram Biosciences, Johnson & Johnson, Simple Trading S.A., and Cardinal Health. Daniel has a strong background in oncology, diagnostic development, and sales.

Daniel Connell completed their Master of Business Administration (MBA) degree in Strategy at HEC Paris from 2014 to 2015. Prior to that, they obtained their Bachelor of Science (B.Sc.) in Biomedical Engineering from Washington University in St. Louis between the years 1996 and 2000.